Editor and Publisher ... Henry enters his thirteen (13) year at RegMed Investors which aggregates, curates and creates bottom-line content of regenerative medicine - stem, gene and cell therapy news providing a "vetted" selection of relevant and high-impact synthesis. He was VP -... More
Instablogged StocksStocks that instabloggers have most recently written about
- 1 Don't Buy The PC Turnaround Argument Just Yet
- 2 Commentary On US Indices And Forex Majors Fo...
- 3 S&P500 Short Term Market Breadth Analog Fore...
- 4 08/28 Thoughts On Technology.
- 5 3 Key Points About Covered Calls
- 1 Chris DeMuth Jr.
- 2 Archman Investor
- 3 Special Situations and Arbs
- 4 Axion Power Host
- 5 Gregory Mannarino